Statement by HHS Secretary Xavier Becerra on Withdrawal of HHS Policy on Laboratory-Developed Tests

16. November 2021 EHR, EMR, Health, HIPAA 0

HHS is withdrawing a policy that limited FDA’s ability to address certain problematic laboratory developed tests (LDTs) for COVID-19.

Powered by WPeMatico